Page 214 - Immunization Practices News Today

Investegate announcements from BioNTech SE, Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age

In a Phase 2/3 clinical trial, the Pfizer-BioNTech COVID-19 Vaccine elicited a strong immune response in this age group Three 3-µg doses had favorable safety profile similar to placebo in young children

By Toby Rogers from his Substack: BREAKING NEWS: CDC launches sneak attack; the ACIP will meet TOMORROW (Friday, June 17) and Saturday, June 18 to extend the mRNA Final Solution to little kids The White House has kept these meetings...

Taipei, June 17 (CNA) An emergency use authorization (EUA) has been granted to Moderna's COVID-19 vaccine for children aged between 6 months and 5 years, Taiwan's Food and Drug Administration (FDA) said in a statement released on Friday.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

In a Phase 2/3 clinical trial, the Pfizer-BioNTech COVID-19 Vaccine elicited a strong immune response in this age group Three 3-µg doses had favorable safety profile similar to placebo in

The emergency use authorization means parents could start vaccinating young children as early as next week, pending CDC approval.

Santa Clara County health officials said they'll begin vaccinating on Tuesday for children ages 6 months to 5 years old.

The plan, which comes ahead of this weekend’s expected final go-ahead from the feds on pediatric vaccinations, is focused on distributing doses via local doctor’s offices and 10 new city-run vaccine hubs, Adams’ office said.

Before shots can be administered to kids as young as 6 months old, the CDC's vaccine advisers are scheduled to vote on updated recommendations this Saturday.